//
J. Harenberg
F. Loesel
J. Douxfils
I. Elalamy
J. Beyer Westendorf
R. Bauersachs
P. Verhamme
M. Crowther
S. Hetjens
C. Weiss
Heidelberg University Hospital, Heidelberg, Germany
DOASENSE GmbH, Heidelberg, Germany
University of Namur, Department of Pharmacy, Namur Thrombosis and Hemostasis Centre, Namur, Belgium
Qualiblood s.a., Namur, Belgium
Hôpital Tenon, Hôpitaux Universitaires Est Parisien, Assistance Publique Hôpitaux de Paris (AP‐HP), Service d'Hématologie Biologique, Paris, France
The First I.M. Sechenov Moscow State Medical University, Obstetrics & Gynaecology, Moscow, Russian Federation
University Hospital 'Carl Gustav Carus', Department of Medicine I, Division Hematology, Dresden, Germany
King's College Hospital, Department of Rheumatology, London, London, United Kingdom
Klinikum Darmstadt GmbH, Department of Vascular Medicine, Darmstadt, Germany
KU Leuven, Department of Cardiovascular Sciences, Leuven, Belgium
McMaster University, Hamilton, Department of Medicine, Thrombosis and Atherosclerosis Research Institute, Hamilton, Canada
Heidelberg University, Department of Statistics, Medical Faculty Mannheim, Mannheim, Germany
Germany
Belgium
France
Russia
United Kingdom
Canada
N/A
N/A
N/A
N/A
rivaroxaban
Pradax
apixaban
Edoxaban
Evithrom
N/A
N/A
NA
N/A
N/A
N/A